CLINICAL_TRIALS
trial_result
· 2016-04-04
Clinical Trial Update: Selegiline Patch for Treatment of Nicotine Dependence [Phase 2]
Summary
A Phase 2 clinical trial evaluating a selegiline transdermal patch for tobacco use disorder has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2016-04-04